Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1371/journal.ppat.1008536 http://scihub22266oqcxt.onion/10.1371/journal.ppat.1008536 32442210!7244094!32442210     free     free     free Warning: file_get_contents(https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&id=32442210&cmd=llinks): Failed to open stream: HTTP request failed! HTTP/1.1 429 Too Many Requests in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 215       PLoS+Pathog 2020 ; 16 (5): e1008536 Nephropedia Template TP {{tp|p=32442210|t=2020. The hallmarks of COVID-19 disease |pdf=|usr=}}{{32442210}} gab.com Text The hallmarks of COVID-19 disease JO: PLoS Pathog http://www.kidney.de/pget.php?&tw=1&pmid=32442210 #FOAvip Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) is a novel coronavirus that has caused a worldwide pandemic of the human respiratory illness COVID-19, resulting in a severe threat to public health and safety. Analysis of the genetic tree suggests that SARS-CoV-2 belongs to the same Betacoronavirus group as severe acute respiratory syndrome coronavirus (SARS-CoV) and Middle East respiratory syndrome coronavirus (MERS-CoV). Although the route for viral transmission remains a mystery, SARS-CoV-2 may have originated in an animal reservoir, likely that of bat. The clinical features of COVID-19, such as fever, cough, shortness of breath, and fatigue, are similar to those of many acute respiratory infections. There is currently no specific treatment for COVID-19, but antiviral therapy combined with supportive care is the main strategy. Here, we summarize recent progress in understanding the epidemiological, virological, and clinical characteristics of COVID-19 and discuss potential targets with existing drugs for the treatment of this emerging zoonotic disease. Twit Text FOAVip The hallmarks of COVID-19 disease ????PLoS Pathog http://www.kidney.de/pget.php?&tw=1&pmid=32442210 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=32442210 #FOAvip English Wikipedia <ref>{{Cite pmid|32442210}}</ref> The hallmarks of COVID-19 disease #MMPMID32442210 Tang D; Comish P; Kang R PLoS Pathog 2020[May]; 16 (5): e1008536 PMID32442210show ga Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) is a novel coronavirus that has caused a worldwide pandemic of the human respiratory illness COVID-19, resulting in a severe threat to public health and safety. Analysis of the genetic tree suggests that SARS-CoV-2 belongs to the same Betacoronavirus group as severe acute respiratory syndrome coronavirus (SARS-CoV) and Middle East respiratory syndrome coronavirus (MERS-CoV). Although the route for viral transmission remains a mystery, SARS-CoV-2 may have originated in an animal reservoir, likely that of bat. The clinical features of COVID-19, such as fever, cough, shortness of breath, and fatigue, are similar to those of many acute respiratory infections. There is currently no specific treatment for COVID-19, but antiviral therapy combined with supportive care is the main strategy. Here, we summarize recent progress in understanding the epidemiological, virological, and clinical characteristics of COVID-19 and discuss potential targets with existing drugs for the treatment of this emerging zoonotic disease. |Animals[MESH] |Betacoronavirus/classification[MESH] |COVID-19[MESH] |Coronavirus Infections/*epidemiology/physiopathology/*therapy[MESH] |Genome, Viral[MESH] |Humans[MESH] |Pandemics[MESH] |Pneumonia, Viral/*epidemiology/physiopathology/*therapy[MESH] |SARS-CoV-2[MESH]The hallmarks of COVID-19 disease (epmc).pdf DeepDyve Pubget Overpricing